277 related articles for article (PubMed ID: 26561527)
1. Guidelines for treatment of immune-mediated cerebellar ataxias.
Mitoma H; Hadjivassiliou M; Honnorat J
Cerebellum Ataxias; 2015; 2():14. PubMed ID: 26561527
[TBL] [Abstract][Full Text] [Related]
2. Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
Mitoma H; Adhikari K; Aeschlimann D; Chattopadhyay P; Hadjivassiliou M; Hampe CS; Honnorat J; Joubert B; Kakei S; Lee J; Manto M; Matsunaga A; Mizusawa H; Nanri K; Shanmugarajah P; Yoneda M; Yuki N
Cerebellum; 2016 Apr; 15(2):213-32. PubMed ID: 25823827
[TBL] [Abstract][Full Text] [Related]
3. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H; Manto M; Hampe CS
Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
[TBL] [Abstract][Full Text] [Related]
5. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
[TBL] [Abstract][Full Text] [Related]
6. Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms.
Mitoma H; Manto M; Hadjivassiliou M
J Mov Disord; 2021 Jan; 14(1):10-28. PubMed ID: 33423437
[TBL] [Abstract][Full Text] [Related]
7. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
Hadjivassiliou M
CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
[TBL] [Abstract][Full Text] [Related]
8. Recognition and management of rapid-onset gluten ataxias: case series.
Newrick L; Hoggard N; Hadjivassiliou M
Cerebellum Ataxias; 2021 Jun; 8(1):16. PubMed ID: 34120658
[TBL] [Abstract][Full Text] [Related]
9. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2023 Jun; 75(6):737-747. PubMed ID: 37287357
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated cerebellar ataxias: from bench to bedside.
Mitoma H; Manto M; Hampe CS
Cerebellum Ataxias; 2017; 4():16. PubMed ID: 28944066
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated acquired ataxias.
Hadjivassiliou M
Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
[TBL] [Abstract][Full Text] [Related]
12. Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges.
Hadjivassiliou M; Manto M; Mitoma H
Brain Sci; 2022 Aug; 12(9):. PubMed ID: 36138901
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated ataxias: Guide to clinicians.
Meira AT; de Moraes MPM; Ferreira MG; Franklin GL; Rezende Filho FM; Teive HAG; Barsottini OGP; Pedroso JL
Parkinsonism Relat Disord; 2023 Dec; 117():105861. PubMed ID: 37748994
[TBL] [Abstract][Full Text] [Related]
14. Treatable Ataxias: How to Find the Needle in the Haystack?
Stezin A; Pal PK
J Mov Disord; 2022 Sep; 15(3):206-226. PubMed ID: 36065614
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Immune-Mediated Cerebellar Ataxias: Pathogenesis, Diagnostic Approaches, Therapies, and Future Challenges-Editorial.
Manto M; Mitoma H
Brain Sci; 2023 Nov; 13(12):. PubMed ID: 38137074
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated ataxias.
Joubert B; Rostásy K; Honnorat J
Handb Clin Neurol; 2018; 155():313-332. PubMed ID: 29891069
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Cerebellar Ataxia in the Context of Systemic Diseases.
Proudfoot M; Wilkins A
Curr Treat Options Neurol; 2017 Nov; 19(12):47. PubMed ID: 29177818
[TBL] [Abstract][Full Text] [Related]
18. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
19. Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis.
Selim M; Drachman DA
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):81-7. PubMed ID: 11413268
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies.
Zeniya S; Sanjo N; Kuwahara H; Ishikawa K; Higashi M; Matsunaga A; Yoneda M; Mizusawa H; Yokota T
Intern Med; 2022; 61(18):2793-2796. PubMed ID: 36104177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]